期刊
MOLECULAR THERAPY
卷 27, 期 4, 页码 710-728出版社
CELL PRESS
DOI: 10.1016/j.ymthe.2019.02.012
关键词
-
资金
- Juvenile Diabetes Research Foundation (JDRF) [3-PDF-2017-383-A-N]
- Misrock Fellowship
mRNA has broad potential as a therapeutic. Current clinical efforts are focused on vaccination, protein replacement therapies, and treatment of genetic diseases. The clinical translation of mRNA therapeutics has been made possible through advances in the design of mRNA manufacturing and intracellular delivery methods. However, broad application of mRNA is still limited by the need for improved delivery systems. In this review, we discuss the challenges for clinical translation of mRNA-based therapeutics, with an emphasis on recent advances in biomaterials and delivery strategies, and we present an overview of the applications of mRNA-based delivery for protein therapy, gene editing, and vaccination.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据